ClinicalTrials.gg
RecruitingNCT07691385TODOMOBUpdated Jul 9, 2026

Prevention of Pain Induced During Bed Bath in Ehpad

An interventional study of Standard personal hygiene and Adapted toilet in Geriatric Care, sponsored by Hôpital NOVO. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by Hôpital NOVO · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Residents of long-term care facilities are subjected to procedures and treatments that may be painful. The prevalence is 90% among older adults living in institutions. Preventing procedure-induced pain is essential, as the consequences can be even more harmful. Induced pain is defined as "short-term pain caused by a healthcare provider, treatment, or care, under predictable circumstances," according to the UPSA Pain Institute.

For these older adults, personal hygiene is performed in bed by nursing assistants and requires frequent handling and repositioning. It includes dressing and undressing, which are sources of pain. Despite this, these activities are repeated daily because they are essential. Addressing pain is a fundamental criterion for quality of life in older adults.

In many cases, these residents require daily premedication with analgesics to prevent pain caused by personal care. For these residents, who are already on multiple medications, the addition of analgesics increases the risk of drug interactions, leading to more frequent side effects.

Read the detailed description

For residents who meet the eligibility criteria, a member of the research team-including the physician and the psychomotor therapist-meets with the resident to inform them about the study and obtain their verbal consent, if possible. If the resident is unable to give consent, the information is provided to the family or a trusted representative by phone or during a visit to the nursing home. The representative may ask the care team any questions and give oral consent after sufficient time to consider the matter.

If consent is given, the resident is then enrolled and randomized into the study.

Randomization will be based on the number of days in the first week (5, 6, or 7 days) and will be performed by the investigator in the eCRF.

The psychomotor therapist will provide expertise that the nursing assistants (NAs) will need to apply during their daily care routines throughout the pilot period in order to make care sessions less unpleasant and painful for the residents.

02

Conditions studied

  • Geriatric Care

Keywords

  • Induced pain
  • Nursing home
  • personal hygiene
  • mobility
  • Non-pharmacological approach
03

In context

Lead sponsor

Hôpital NOVO is the lead sponsor of 70 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Inclusion criteria common to all groups

    • Senior residents
    • With a stable Algoplus score of 2 or higher
    • Information provided to and consent obtained from the resident or their trusted representative
    • Eligible for intervention by a psychomotor therapist

Criteria specific to Group 1:

  • Residents requiring high doses of analgesics (Level 3) before bathing
  • GIR (Iso-Resource Group) 1, with multiple medical conditions

Criteria specific to Group 2:

  • Residents requiring Level 1 or 2 analgesics before bathing
  • GIR (Iso-Resource Group) 2 or 3, with multiple medical conditions

Criteria specific to Group 3:

  • Residents experiencing pain without analgesics prior to bathing
  • GIR (Iso-Resource Group) 3 or 4, with multiple medical conditions

Exclusion Criteria:

  • Resident who has previously received treatment from a psychomotor therapist
  • Resident capable of washing at the sink (partially) or independently
  • Under guardianship, conservatorship, or judicial protection
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Resident GIR1

    Resident (GIR (Iso-Resource Group) 1) requiring high doses of pain medication (Level 3) before bathing

    Other: Standard personal hygiene · Other: Adapted toilet

  • Experimental
    Resident GIR 2-3

    Residents (GIR (Iso-Resource Group) 2 or 3) who require Level 1 or 2 analgesics before bathing

    Other: Standard personal hygiene · Other: Adapted toilet

  • Experimental
    Resident GIR 3-4

    Residents (GIR (Iso-Resource Group) 3 or 4 ) without analgesics before bathing

    Other: Standard personal hygiene · Other: Adapted toilet

Interventions

  • OtherStandard personal hygiene

    Caregivers follow the standard guidelines for personal hygiene. They are not trained by the psychomotor therapist.

  • OtherAdapted toilet

    Care assistants follow the psychomotor therapist's recommendations for providing appropriate personal care to residents. A new approach to pain prevention developed by a psychomotor therapist and shared with nursing assistants who assist with bedside hygiene for residents experiencing pain of 2 or higher on the ALGOPLUS scale.

06

What researchers measure

Primary outcomes

  1. Pain reduction with ALGOPLUS

    Pain measured using the ALGOPLUS scale by one independent evaluator (an experienced medical or paramedical professional) after bathing.

    Time frame: 4 weeks

Secondary outcomes

  1. Drug profile

    Change in the dose of pain medication received, by 3 categories of residents

    Time frame: 4 weeks

  2. Satisfaction of care workers

    Questionnaire on changes in practices and how they were perceived, before the study and after each bath

    Time frame: 4 weeks

  3. Bathing Process

    Number of caregivers, duration of care

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2026 (actual). Primary completion is estimated for Oct 2027, 15 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 23, 2026
First posted
Jul 8, 2026
StartActual
Jul 6, 2026
Primary completionEst.
Oct 31, 2027
CompletionEst.
Nov 30, 2027
Last update
Jul 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07691385
Lead sponsor
Hôpital NOVO
Responsible party
Sponsor
First posted
Jul 8, 2026
Start date
Jul 6, 2026
Primary completion
Oct 31, 2027 (estimated)
Completion
Nov 30, 2027 (estimated)
Last update
Jul 9, 2026

Study contacts

Vella QUILLIEN
Contact
vella.quillien@ght-novo.fr
01 30 75 51 75
Vella QUIILIEN
principal investigator · Hôpital NOVO

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion